{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:29:31Z","timestamp":1788391771725,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1492,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1002\/hep.24519","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T17:48:43Z","timestamp":1309974523000},"page":"724-728","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Terlipressin: An Asset for Hepatologists!"],"prefix":"10.1097","volume":"54","author":[{"given":"S. K.","family":"Sarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-34-20241202","first-page":"922938","article-title":"Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Preve Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"GarciaTsao","year":"2007","journal-title":"HEPATOLOGY"},{"key":"R2-34-20241202","doi-asserted-by":"crossref","first-page":"607624","DOI":"10.1007\/s12072-010-9236-9","article-title":"Asian Pacific Association for the Study of the Liver (APASL) Working Party on Portal Hypertension. Di Diagnosis and management of acute variceal bleeding: Asian Pacific Association for Study of the Liver recommendations.","volume":"5","author":"Sarin","year":"2011","journal-title":"Hepatol Int"},{"key":"R3-34-20241202","doi-asserted-by":"crossref","first-page":"762768","DOI":"10.1016\/j.jhep.2010.06.004","article-title":"Faculty revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension.","volume":"53","author":"de Franchis","year":"2010","journal-title":"J Hepatol"},{"key":"R4-34-20241202","first-page":"17641772","article-title":"Portal hypertension and variceal bleedingunresolved issues. Sum Summary of an American Association for the study of liver diseases and European Association for the study of the liver singletopic conference.","volume":"47","author":"GarciaTsao","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R5-34-20241202","doi-asserted-by":"crossref","first-page":"9961003","DOI":"10.1111\/j.1440-1746.2010.06596.x","article-title":"Prophylaxis of Hepatic Encephalopathy in Acute Variceal Bleed: A Randomized Controlled Trial of Lactulose Versus no Lactulose.","volume":"26","author":"Sharma","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R6-34-20241202","first-page":"CD002233","article-title":"Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients.","volume":"3","author":"DAmico","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R7-34-20241202","doi-asserted-by":"crossref","first-page":"229236","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"R8-34-20241202","first-page":"13101318","article-title":"Diagnosis, prevention and treatment of the hepatorenal syndrome in cirrhosis. A cons A consensus workshop of the international ascites club.","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"R9-34-20241202","first-page":"20642077","article-title":"Acute kidney injury in cirrhosis.","volume":"48","author":"GarciaTsao","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R11-34-20241202","doi-asserted-by":"crossref","first-page":"385394","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.","volume":"43","author":"Moreau","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R12-34-20241202","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome.","volume":"4","author":"Gluud","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-34-20241202","doi-asserted-by":"crossref","first-page":"576584","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.","volume":"51","author":"Gluud","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R14-34-20241202","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1034\/j.1600-0676.2000.020001051.x","article-title":"Central and systemic hemodynamic effects of terlipressin in portal hypertensive patients.","volume":"20","author":"Moller","year":"2000","journal-title":"Liver"},{"key":"R15-34-20241202","doi-asserted-by":"crossref","first-page":"17911797","DOI":"10.1111\/j.1440-1746.2009.05873.x","article-title":"Effects of Terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.","volume":"24","author":"Narahara","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"R16-34-20241202","doi-asserted-by":"crossref","first-page":"417418","DOI":"10.1136\/gut.2009.198382","article-title":"Hyponatraemia during terlipressin therapy.","volume":"59","author":"Krag","year":"2010","journal-title":"Gut"},{"key":"R17-34-20241202","first-page":"152156","article-title":"Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebocontrolled clinical trial.","volume":"18","author":"Solanski","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-34-20241202","first-page":"941948","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.","volume":"35","author":"Ortega","year":"2002","journal-title":"HEPATOLOGY"},{"key":"R19-34-20241202","doi-asserted-by":"crossref","first-page":"13601368","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized prospective doubleblind placebocontrolled trial of terlipressin for type 1 hepatorenal syndrome.","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"R20-34-20241202","first-page":"13521359","article-title":"Terlipressin and albumin versus albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.","volume":"134","author":"MartinLlahi","year":"2008","journal-title":"Gastroenterology"},{"key":"R21-34-20241202","doi-asserted-by":"crossref","first-page":"16891697","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R22-34-20241202","first-page":"20642077","article-title":"Acute kidney injury in cirrhosis.","volume":"48","author":"GarciaTsao","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R23-34-20241202","doi-asserted-by":"crossref","first-page":"714715","DOI":"10.1002\/hep.24116","article-title":"Hyponatremia in patients with acute variceal bleeding treated with terlipressin.","volume":"53","author":"Sharma","year":"2011","journal-title":"HEPATOLOGY"},{"key":"R24-34-20241202","doi-asserted-by":"crossref","first-page":"17831790","DOI":"10.1002\/hep.23893","article-title":"Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension.","volume":"52","author":"Sola","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R25-34-20241202","doi-asserted-by":"crossref","first-page":"385394","DOI":"10.1002\/hep.21094","article-title":"The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond.","volume":"43","author":"Moreau","year":"2006","journal-title":"HEPATOLOGY"},{"key":"R26-34-20241202","doi-asserted-by":"crossref","first-page":"219226","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.","volume":"51","author":"Nazar","year":"2010","journal-title":"HEPATOLOGY"},{"key":"R29-34-20241202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/j.gastro.2009.03.064","article-title":"Terlipressin for hepatorenal syndrome: continuous infusion as an alternative to intravenous bolus administration.","volume":"137","author":"Gerbes","year":"2009","journal-title":"Gastroenterology"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.24519","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201108000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,2]],"date-time":"2024-12-02T17:03:33Z","timestamp":1733159013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201108000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.24519","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}